IRIS
TOSCANO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.272
NA - Nord America 16.510
AS - Asia 11.046
SA - Sud America 3.721
AF - Africa 315
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
Totale 49.884
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.142
RU - Federazione Russa 9.624
SG - Singapore 4.689
BR - Brasile 3.167
CN - Cina 3.071
IE - Irlanda 2.398
SE - Svezia 1.603
HK - Hong Kong 1.248
IT - Italia 1.184
DE - Germania 767
VN - Vietnam 606
FR - Francia 555
UA - Ucraina 524
FI - Finlandia 469
PL - Polonia 379
IN - India 336
GB - Regno Unito 308
BD - Bangladesh 187
AR - Argentina 183
CA - Canada 162
MX - Messico 112
TR - Turchia 106
NL - Olanda 103
ID - Indonesia 93
ZA - Sudafrica 93
EC - Ecuador 92
IQ - Iraq 87
JP - Giappone 86
BE - Belgio 76
AT - Austria 72
CO - Colombia 71
PK - Pakistan 68
VE - Venezuela 64
MA - Marocco 56
UZ - Uzbekistan 55
PY - Paraguay 51
TH - Thailandia 50
ES - Italia 42
CL - Cile 36
KE - Kenya 34
TN - Tunisia 32
JO - Giordania 28
PE - Perù 28
PH - Filippine 28
LT - Lituania 27
IR - Iran 26
KZ - Kazakistan 26
SA - Arabia Saudita 26
MY - Malesia 25
IL - Israele 24
AZ - Azerbaigian 23
CI - Costa d'Avorio 23
CZ - Repubblica Ceca 23
JM - Giamaica 23
AE - Emirati Arabi Uniti 21
EG - Egitto 20
DZ - Algeria 19
NP - Nepal 19
OM - Oman 18
DO - Repubblica Dominicana 17
LB - Libano 17
UY - Uruguay 16
AL - Albania 13
HR - Croazia 13
KR - Corea 12
BO - Bolivia 11
CR - Costa Rica 11
KG - Kirghizistan 11
RS - Serbia 11
HN - Honduras 10
RO - Romania 9
AU - Australia 8
CH - Svizzera 8
GT - Guatemala 8
PA - Panama 8
ET - Etiopia 7
GR - Grecia 7
PS - Palestinian Territory 7
PT - Portogallo 7
SN - Senegal 7
AM - Armenia 6
BG - Bulgaria 6
DK - Danimarca 6
EU - Europa 6
LV - Lettonia 6
NI - Nicaragua 6
QA - Qatar 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
GA - Gabon 5
HU - Ungheria 5
KW - Kuwait 5
LK - Sri Lanka 5
SY - Repubblica araba siriana 5
AO - Angola 4
BH - Bahrain 4
KH - Cambogia 4
MN - Mongolia 4
CY - Cipro 3
LA - Repubblica Popolare Democratica del Laos 3
Totale 49.825
Salva come PNG Salva come JPEG
Città #
Moscow 3.029
Ashburn 2.607
Dublin 2.396
Singapore 2.245
Dallas 2.144
Chandler 1.479
Hong Kong 1.248
Jacksonville 1.145
Nyköping 1.023
Beijing 953
San Jose 764
The Dalles 557
Princeton 440
Los Angeles 417
Medford 406
Messina 395
Lauterbourg 384
Warsaw 368
Cambridge 333
Des Moines 316
Dearborn 308
Ann Arbor 286
New York 276
São Paulo 236
Buffalo 198
Ho Chi Minh City 195
Council Bluffs 179
Munich 175
Wilmington 149
Tianjin 145
Boardman 139
Guangzhou 118
Hanoi 118
Jinan 117
San Mateo 113
Shenyang 107
Redondo Beach 104
Orem 101
Frankfurt am Main 99
Santa Clara 97
Rio de Janeiro 93
Nanjing 83
Belo Horizonte 77
Rome 77
Tokyo 75
Hyderabad 71
Turku 71
Houston 70
Ningbo 67
Chennai 64
Brooklyn 62
Helsinki 61
Brasília 58
Nuremberg 57
Zhengzhou 56
Woodbridge 53
Denver 52
Hebei 52
San Francisco 52
Brussels 51
Bremen 49
Curitiba 49
Johannesburg 49
Atlanta 48
Hangzhou 47
Seattle 47
Tashkent 47
Amsterdam 46
Shanghai 46
Shenzhen 46
Falls Church 42
Jakarta 42
Milan 42
Pune 42
Bangkok 41
Vienna 41
Campinas 40
Taizhou 40
Montreal 39
Lancaster 38
London 38
Chicago 37
Dong Ket 36
Porto Alegre 36
Catania 35
Guayaquil 35
Mexico City 35
Stockholm 34
Haikou 32
Nairobi 32
Salvador 32
Boston 31
Mumbai 31
Toronto 31
Fortaleza 29
Fuzhou 29
Manaus 29
Nanchang 29
Phoenix 29
Quito 29
Totale 28.741
Salva come PNG Salva come JPEG
Nome #
The relationship between sleep quality and ratio of house size/number of people in chronic migraineurs during Covid-19 lockdown. 304
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 285
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 258
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 251
A CMT1A PATIENT WITH PAINFUL AND DISABLING SYMPTOMS: FAST RECOVERY AFTER IVIG TREATMENT. 250
Clinical and pathological features of focal myositis 248
Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports 221
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 216
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 211
A cytochemical study of apoptosis in metabolic myopathies 210
Atypical posterior reversible encephalopathy syndrome with hemispheric brainstem and spinal cord involvement in a patient with acute kidney injury – a case report. 209
A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies 208
A life threatening case of β-enolase deficiency 203
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 198
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 198
A decreased muscle content of HPRG correlates with the reduction of AMP deaminase activity observed in patients affected by myoadenylate deficiencies 194
A novel mutation in KIF5A gene causing hereditary spastic paraplegia with axonal neuropathy. 193
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 193
"Dropped- head" syndrome due to isolated myositis of neck extensor muscles: MRI findings 191
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 190
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 190
Auditory system involvement study in 20 patients with late-onset Pompe disease 187
Community-acquired enterococcal meningitis caused by Enterococcus casseliflavus: first case report 185
Pimozide and pancreatic cancer in diabetic chorea: a case report 185
A benign case of congenital myotonic dystrophy 181
Variants of the circle of Willis in ischemic stroke patients 181
A case of vacuolar myopathy during the course of chronic hepatitis C. 180
Bezafibrate-induced myopathy: no evidence for defects in muscle metabolism. 180
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 180
A MRI evaluation of respiratory function in patients with the late onset form of Pompe disease 178
ANT1 is reduced in sporadic inclusion body myositis. 177
Sleep and sleep‐modifying factors in chronic migraine patients during the COVID‐19 lockdown 175
Analysis of lipid profile in lipid storage myopathy 175
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 175
A genetic modifier of symptom onset in Pompe disease 175
Ischemic stroke and reperfusion therapies in diabetic patients 175
Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias 174
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 174
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 173
A study of auditory system in 20 patients with late onset Pompe disease 170
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 170
Isolated Insular Stroke: Clinical Presentation 170
Enterococcal meningitis caused by Enterococcus casseliflavus. First case report. 169
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 169
A novel Cx32 mutation with unusual phenotype. 169
211th ENMC International Workshop:: Development of diagnostic criteria and management strategies for McArdle Disease and related rare glycogenolytic disorders to improve standards of care. 17–19 April 2015, Naarden, The Netherlands 168
A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy 166
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 166
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 166
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 166
Management of Teenage Stroke in the Acute Setting: Two Case Reports 166
Apoptosis and apoptosis-related proteins in thyroid myopathies 165
Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy 165
Autoimmune juvenile limb-girdle myasthenia 165
AUDITORY SYSTEM INVOLVEMENT IN LATE ONSET POMPE DISEASE: A STUDY OF 20 ITALIAN PATIENTS 164
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 162
Acute ischemic stroke due to endocarditis from Brucella infection 161
Clinical and electrophysiological characterization in a cohort of italian patients with different forms of hereditary spastic paraplegia 159
Deficit multiplo di Acyl-CoA deidrogenasi responsivo alla riboflavina (MADD-RR): studio clinico, biochimico, genetico e spettroscopico 158
A NOVEL MUTATION IN KIF5A GENE CAUSING HEREDITARY SPASTIC PARAPLEGIA WITH AXONAL NEUROPATHY; 158
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 158
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 157
Auditory system involvement study in 20 patients with lateonset pompe disease 157
Acute parkinsonism as first manifestation of systemic lupus erythematosus unmasked by CMV infection. 157
A novel mithocondrial tRNAHys point mutation in a patient with PSP-like phenotype. 156
Flecainide-responsive myotonia permanens with SNEL onset: A new case and literature review 156
Chronic migraine in the first COVID‐19 lockdown: the impact of sleep, remote working, and other life/psychological changes 156
Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci 155
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 155
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 155
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 155
Primary CNS infiltrative parenchymal histiocytosis 155
Dolori muscolari, deficit di forza e/o disturbi sensitivi 154
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 154
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 154
Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance 154
Homozygosity for the common GAA gene splice site mutation c.-32-13T>G in Pompe disease is associated with the classical adult phenotypical spectrum 153
208th ENMC International Workshop: Formation of a European Network to develop a European data sharing model and treatment guidelines for Pompe disease. 152
Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study 152
Severe congenital myasthenic syndrome associated with novel biallelic mutation of the CHRND gene 152
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07) 151
Fatal R631C mutation is also present in the adult form of CPTII deficiency 151
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 149
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 149
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 148
Severe rhabdomyolysis in a patient with “Heat Stroke” 148
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 148
Miopatie metaboliche 146
Recurrent intracranial hemorrhage and cerebral venous sinus thrombosis: an atypical case of Neuro-Behçet’s Syndrome 146
Minor stroke with bilateral acute infarctions and combined vascular anomalies: A complex case report 146
Charcot-Marie-Tooth type X: unusual phenotype of a novel CX32 mutation 145
About the physiopathological mechanism of statin myopathy: evidence of a diffuse reduction of CoQ10 levels in skeletal muscle. 145
Ischemic stroke due to hypoperfusion in a patient with a previously unrecognized Danon disease 145
Endocrine myopathies: Clinical and histopathological features of the major forms 145
Facioscapulohumeral Muscular Dystrophy and Poliomyelitis followed by Multiple Sclerosis: A “triple trouble” case report and review of the literature on the association of MS and muscle disorders 145
Repeated reperfusion treatment in recurrent ischemic stroke: A retrospective single-center case series 145
Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray. 144
Are there ERT defined guidelines for Pompe disease? 144
Juvenile limb-girdle myasthenia gravis 143
CEREBELLAR ATAXIA AND SEVERE MUSCLE CoQ10 DEFICIENCY IN A PATIENT WITH A NOVEL MUTATION IN ADCK3 143
Totale 17.326
Salva come PNG Salva come JPEG
Categoria #
all - tutte 177.414
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 177.414
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 0 0 0 0 0 0 82
2021/20222.607 19 330 27 133 139 40 241 118 58 203 318 981
2022/20236.263 549 519 299 406 413 586 87 347 2.802 23 168 64
2023/20241.757 136 246 137 138 123 356 22 173 14 152 48 212
2024/20258.635 140 74 134 526 390 303 229 1.594 2.176 475 958 1.636
2025/202625.226 1.134 1.782 2.236 1.841 1.960 5.167 3.041 2.948 3.046 1.140 507 424
Totale 50.849